RxDoctor Payments Data

Anne Alexandrov

Acute Care · Memphis, TNNPI 1447605753

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 90.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $47,918 and has fallen 99.1% since, to $449 in 2025. Among acute care clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$109,750in general payments, 2019–2025

Across 170 payments — averaging $645.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$100K
  • Genentech USA, Inc.$7K
  • Medtronic$997
  • Viz.ai, Inc.$945
  • Longeviti Neuro Solutions Inc$340
  • Genentech, Inc.$234
  • plus $558 from 5 others

What the payments were for

  • Consulting fees$6,5256%
  • Speaking & faculty fees$61,50056%
  • Travel & lodging$34,28331%
  • Food & beverage$7,3627%
  • Education$800%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$109,750 in reported general payments places this provider in the 95th percentile of 738 acute care providers in Tennessee.

See all acute care providers in Tennessee

Other acute care in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →